HC Wainwright Issues Negative Estimate for BTAI Earnings
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Free Report) – HC Wainwright cut their Q2 2025 earnings per share estimates for shares of BioXcel Therapeutics in a research note issued to investors on Monday, June 23rd. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($2.30) per share for the quarter, down […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Free Report) – HC Wainwright cut their Q2 2025 earnings per share estimates for shares of BioXcel Therapeutics in a research note issued to investors on Monday, June 23rd. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($2.30) per share for the quarter, down […]
